Relevant conflicts of interest/financial disclosures: S.B. has been supported by grants from the Bundesministerium for Bildung und Forschung. C.S. has received research funding from the Hugelschaffner-Stiftung. R.H. has received research funding from the Deutsche Parkinson Vereinigung (dPV), the Bundesministerium für Bildung und Forschung, and from the Goethe-University of Frankfurt. All other authors report no disclosures related to this article.
The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy
Version of Record online: 15 NOV 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 29, Issue 3, pages 380–387, March 2014
How to Cite
Baudrexel, S., Seifried, C., Penndorf, B., Klein, J. C., Middendorp, M., Steinmetz, H., Grünwald, F. and Hilker, R. (2014), The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Mov. Disord., 29: 380–387. doi: 10.1002/mds.25749
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 17 MAR 2014
- Version of Record online: 15 NOV 2013
- Manuscript Accepted: 18 OCT 2013
- Manuscript Revised: 2 OCT 2013
- Manuscript Received: 28 FEB 2013
Additional Supporting Information may be found in the online version of this article.
|mds25749-sup-0001-supptab1.doc||46K||Supplementary Table S1: Comparison of image parameters with respect to the most and least affected body side|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.